Pharmesis International Ltd. (SGX:BFK)
Singapore · Delayed Price · Currency is SGD 0.1250
0.00 (0.00%)
At close: Aug 14, 2026
Pharmesis International Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4 | 12 | 18 | 3 | 3 | 3 | |
Market Cap Growth | -73.12% | -33.91% | 573.89% | 7.89% | -27.33% | -47.37% |
Enterprise Value | 6 | 14 | 21 | 5 | 4 | 4 |
Last Close Price | 0.13 | 0.35 | 0.53 | 0.09 | 0.10 | 0.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 11.78 | - | - | 13.89 |
PS Ratio | 0.73 | 1.50 | 1.44 | 0.32 | 0.26 | 0.31 |
PB Ratio | 0.41 | 1.18 | 1.58 | 0.27 | 0.23 | 0.27 |
P/TBV Ratio | 0.42 | 1.21 | 1.62 | 0.29 | 0.25 | 0.29 |
P/FCF Ratio | 4.72 | 27.75 | - | - | 2.04 | - |
P/OCF Ratio | 4.73 | 24.76 | - | - | 1.97 | 24.90 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.09 | 1.78 | 1.67 | 0.56 | 0.42 | 0.40 |
EV/EBITDA Ratio | - | - | 34.91 | - | - | 8.93 |
EV/EBIT Ratio | - | - | 55.85 | - | - | 19.59 |
EV/FCF Ratio | 7.00 | 32.93 | - | - | 3.34 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.30 | 0.28 | 0.26 | 0.31 | 0.29 | 0.28 |
Debt / EBITDA Ratio | - | - | 4.12 | - | - | 5.89 |
Debt / FCF Ratio | 3.50 | 6.65 | - | - | 2.61 | - |
Net Debt / Equity Ratio | 0.20 | 0.21 | 0.19 | 0.13 | -0.06 | 0.05 |
Net Debt / EBITDA Ratio | -1.67 | -3.78 | 3.60 | -4.36 | 2.68 | 1.36 |
Net Debt / FCF Ratio | 2.28 | 4.82 | -3.29 | -0.58 | -0.50 | -3.40 |
Asset Turnover | 0.33 | 0.41 | 0.67 | 0.50 | 0.53 | 0.57 |
Inventory Turnover | 1.33 | 1.83 | 2.95 | 1.88 | 2.65 | 3.20 |
Quick Ratio | 0.43 | 0.55 | 0.79 | 0.58 | 0.82 | 0.92 |
Current Ratio | 0.86 | 0.96 | 1.06 | 1.09 | 1.12 | 1.21 |
Return on Equity (ROE) | -13.09% | -7.34% | 13.14% | -8.82% | -5.42% | 3.33% |
Return on Assets (ROA) | -5.99% | -3.14% | 1.25% | -1.90% | -1.66% | 0.72% |
Return on Invested Capital (ROIC) | -13.61% | -7.57% | 2.71% | -4.86% | -4.32% | 1.62% |
Return on Capital Employed (ROCE) | -16.20% | -9.50% | 3.20% | -5.10% | -4.30% | 1.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -35.04% | -6.57% | 8.49% | -34.12% | -27.61% | 7.20% |
FCF Yield | 21.19% | 3.60% | -3.63% | -83.72% | 49.05% | -5.71% |
Buyback Yield / Dilution | 0.05% | -6.13% | -13.08% | -14.85% | - | - |